ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, vol.41, no.3, pp.75-82, 2019 (SCI-Expanded, Scopus)
OBJECTIVE: To observe the combining effect of ellagic acid (EA) with bevacizumab (BEV) on cadherin switch and angiogenesis of C6-glioma cell line.